Serum PSA Hemodilution Among Obese Men Undergoing Screening In The Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial

Main Category: Urology / Nephrology
Also Included In: Prostate / Prostate Cancer;  Obesity / Weight Loss / Fitness;  Cancer / Oncology
Article Date: 30 Apr 2009 - 2:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:2 stars

2 (1 votes)


UroToday.com - This study reported in Cancer, Epidemiology, Biomarkers and Prevention used the same Prostate, Lung, Colorectal and Ovarian (PLCO) database as that by Andriole and colleagues in the NEJM article recently covered in Urotoday1. It is previously proposed that PSA levels in obese men could be due to hemodilution secondary to increased circulating blood volume. This study evaluated that phenomenon among 38,349 men randomized to the screened group of PLCO.

Body surface area, plasma volume and PSA mass were calculated for study participants. Mean age of me analyzed was 62.3 years. There was an inverse relationship between age and body mass index (BMI) that was statistically significant. The mean and median BMI were 27.6 and 27.0 kg/m2, respectively. Half of all men were classified as overweight and 23.5% as obese or morbidly obese. The mean PSA concentration decreased from 1.27ng/ml in normal weight men to 1.07ng/ml in morbidly obese men. Estimated mean plasma volume increased with increasing BMI from 3.19 liters in normal weight men to 3.94 in morbidly obese men. Estimated PSA mass (calculated as PSA concentration x plasma volume) did not demonstrate significant association with BMI.

While the PLCO confirms an inverse correlation between PSA and BMI, the change in PSA from normal to morbidly obese men is only 16%.

Grubb RL 3rd, Black A, Izmirlian G, Hickey TP, Pinsky PF, Mabie JE, Riley TL, Ragard LR, Prorok PC, Berg CD, Crawford ED, Church TR, Andriole GL Jr; PLCO Project Team

Cancer Epidemiol Biomarkers Prev. 2009 Mar;18(3):748-51
10.1158/1055-9965.EPI-08-0938

Reference:
1. Andriole GL, et.al., N Engl J Med. 2009 Mar 26;360(13):1310-9

Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2009 - UroToday

Article adapted by Medical News Today from original press release.
Visit our urology / nephrology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Urotoday. "Serum PSA Hemodilution Among Obese Men Undergoing Screening In The Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial." Medical News Today. MediLexicon, Intl., 30 Apr. 2009. Web.
14 Feb. 2012. <http://www.medicalnewstoday.com/releases/148179.php>

APA
Urotoday. (2009, April 30). "Serum PSA Hemodilution Among Obese Men Undergoing Screening In The Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/148179.php.

Please note: If no author information is provided, the source is cited instead.


Urology / Nephrology

Most Popular Articles



Follow Our Urology News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Urology / Nephrology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »